Keloids may complicate wound healing secondary to trauma, inflammation or surgical incision. Although various treatment modalities have been used with variable degrees of success, overall recurrence rates have remained unacceptably high.
Methods
The present study involved 80 patients with keloids of at least one-years' duration. Following total surgical excision of the keloid, a single dose of 5-fluorouracil was injected into the edges of the healing wound on postoperative day 9 together with botulinum toxin. The concentration of 5-fluorouracil used was 50 mg/mL and approximately 0.4 mL was infiltrated per cm of wound tissue, with the total dose <500 mg. The concentration of botulinum toxin was 50 IU/mL with the total dose <140 IU.
Results
Patients were followed-up for 17 to 24 months and a recurrence rate of 3.75% was found, which was significantly lower than in previously reported studies using other therapeutic modalities.
Conclusion
The author recommends that this treatment be routinely applied to all keloids because it is significantly more effective than those described by other authors.
BermanBBieleyHC. Keloids.J Am Acad Dermatol1995; 33: 117–21.
2.
PeacockEEJrMaddenJWTrierWC. Biological basis for the treatment of keloids and hypertrophic scars.South Med J1970; 63: 755–83.
3.
ManciniREQuaifeJW. Histogenesis of experimentally produced keloids.J Invest Dermatol1962; 38: 142–57.
4.
RockwellWBCohenIKEhrlichHP. Keloids and hypertrophic scars: A comprehensive review.Plast Reconstr Surg1989; 84: 827–33.
5.
TredgetEENedelecBScottPGGhaharyA. Hypertrophic scars, keloids and contractures: The cellular and molecular basis of therapy.Surg Clin North Am1997; 77: 701–39.
6.
TuanTLZhuJYSunBNichterLSNimniMELaugWE. Elevated levels of plasminogen activator inhibitor-1 may account for the altered fibrinolysis by keloid fibroblasts.J Invest Dermatol1996; 106: 1007–10.
7.
KischerCWThiesACChvapilM. Perivascular myofibroblasts and microvascular occlusion in hypertrophic scars and keloids.Hum Pathol1982; 13: 819–23.
8.
FriedmanDWBoydCDMackenzieJWNortonPOlsonRMDeakSB. Regulation of collagen gene expression in keloids and hypertrophic scars.J Surg Res1993; 55: 214–9.
9.
UittoJPerejdaAJAbergelRPChuMLRamirezF. Altered steady-state ratio of type I/III procollagen mRNAs correlates with selectively increased type I procollagen biosynthesis in cultured keloid fibroblasts.Proc Natl Acad Sci USA1985; 82: 5935–41.
10.
AbergelRPPizzurroDMeekerCA. Biochemical composition of the connective tissue in keloids and analysis of collagen metabolism in keloid fibroblast cultures.J Invest Dermatol1985; 84: 384–8.
11.
McCoyBJCohenIK. Collagenase in keloid biopsies and fibroblasts.Connect Tissue Res1982; 9: 181–5.
12.
RussellSBTrupinKMRodriguez EatonSRussellJDTrupinJS. Reduced growth-factor requirement of keloid-derived fibroblasts may account for tumor growth.Proc Natl Acad Sci USA1988; 85: 587–91.
13.
GarnerWL. Karmiol S, Rodriguez JL, Smith DJ, Jr, Phan SH. Phenotypic differences in cytokine responsiveness of hypertrophic scars versus normal dermal fibroblasts.J Invest Dermatol1993; 101: 875–80.
14.
ChinGSLiuWPeledZ. Differential expression of transforming growth factor-B receptors I and II and activation of Smad 3 in keloid fibroblasts.Plast Reconstr Surg2001; 108: 423–8.
15.
HaisaMOkochiHGrotendorstGR. Elevated levels of PDGF alpha receptors in keloid fibroblasts contribute to an enhanced response to PDGF.J Invest Dermatol1994; 103: 560–6.
16.
LarrabeeWFJrEastCAJaffeHSStephensonCPetersonKE. Intralesional interferon gamma treatment for keloids and hypertrophic scars.Arch Otolaryngol Head Neck Surg1990; 116: 1159–64.
17.
CosmanBWolffM. Correlation of keloid recurrence with completeness of local excision: A negative report.Plast Reconstr Surg1972; 50: 163–6.
18.
MarshDJPacificoMDGaultDT. Keloids: When excision is the better part of valor.Plast Reconstr Surg2008; 121: 214–5.
ParkTHSeoSWKimJKChangCH. Outcomes of surgical excision with pressure therapy using magnets and identification of risk factors for recurrent keloidsPlast Reconstr Surg2011; 128:431–6.
21.
JemecG. B. Linear atrophy following intralesional steroid injections.J Dermatol Surg Oncol1988; 14: 88–92.
22.
DoornbosJFStoffelTJHassAC. The role of kilovoltage irradiation in the treatment of keloids.Int J Radiat Oncol Biol Phys1990; 18: 833–9.
23.
OgawaRYoshitatsuSYoshidaKMiyashitaT. Is radiation therapy for keloids acceptable? The risk of radiation-induced carcinogenesis.Plast Reconstr Surg2009; 124: 1196–7.
FultoJEJr. Silicone gel sheeting for the prevention and management of evolving hypertrophic and keloid scars.Dermatol Surg1995; 21: 947–55.
26.
DierickxCGoldmanMPFitzpatrickRE. Laser treatment of erythematous/hyertrophic and pigmented scars in 26 patients.Plast Reconstr Surg1995; 95: 84–90.
27.
AsilianADaroughehAShariatiF. New combination of triamcinolone, 5-fluorouracil, and pulsed-dye laser for treatment of keloid and hypertrophic scars.Dermatol Surg2006; 32: 907–12.
28.
Har-ShaiYAmarMSaboE. Intralesional cryotherapy for enhancing the involution of hypertrophic scars and keloids.Plast Reconstr Surg2003; 111: 1841–52.
29.
The Fluorouracil Filtering Surgery Study Group: 3-year follow-up of the fluorouracil filtering surgery study.Am J Ophthalmol1993; 115:82–8.
30.
LanignanLSturmerJBaezKAHitchingsRAKhawPT. Single intraoperative applications of 5-fluorouracil during filteration.Br J Ophthalmol1994; 78: 33–40.
31.
UppalRSKhan KakarSTalasGChapmanPMcGroutherDA. The effects of a single dose of 5-fluorouracil on keloid scars: A clinical trial of timed wound irrigation after extralesional excision.Plast Reconstr Surg2001; 108: 1218–24.
32.
FitzpatrickR. Treatment of inflamed hypertrophic scars using intralesional 5-FU.Dermatol Surg1999; 25224–30.
33.
KontochristopoulosGStefanakiCPanagiotopoulosA. Intralesional 5-fluorouracil in the treatment of keloids: An open clinical and histopathologic study.J Am Acad Dermatol2005; 52: 474–81.
34.
NandaSReddyBS. Intralesional 5-fluorouracil as a treatment modality of keloids.Dermatol Surg2004; 30: 54–60.
35.
WilsonAM. Use of botulinum toxin type A to prevent widening of facial scars.Plast Reconstr Surg2006; 117: 1758–66.
36.
ZhiboXMiaoboZIntralesional botulinum toxin type A injection as a new treatment measure for keloids.Plast Reconstr Surg2009; 124:276–7.
37.
WilsonAMMcGroutherDAEastwoodMBrownRA. The effect of burn blister fluid on fibroblast contraction.Burns1997; 23: 306–12.
38.
WilsonAM. Widening of scars: Foe coaxed into friend?Plast Reconstr Surg2000; 106: 1488–93.
39.
DavisonSPDayanJHClemensMWSonniSWangACraneA. Efficacy of intralesional 5-fluorouracil and triamcinolone in the treatment of keloids.Aesthetic Surg J2009; 29: 40–6.
